NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 53 filers reported holding NEON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $11,682,000 | +187.9% | 4,425 | +28.7% | 0.00% | – |
Q4 2019 | $4,058,000 | +0.6% | 3,439 | +46.7% | 0.00% | – |
Q3 2019 | $4,032,000 | -63.0% | 2,344 | +1.8% | 0.00% | – |
Q2 2019 | $10,911,000 | -47.6% | 2,302 | -28.6% | 0.00% | – |
Q1 2019 | $20,827,000 | +22786.8% | 3,224 | +17811.1% | 0.00% | – |
Q4 2018 | $91,000 | – | 18 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 9,741,636 | $46,175,000 | 19.63% |
Endurant Capital Management LP | 465,650 | $2,207,000 | 0.87% |
HARVARD MANAGEMENT CO INC | 505,871 | $2,398,000 | 0.59% |
Partner Investment Management, L.P. | 103,596 | $491,000 | 0.52% |
MEITAV INVESTMENT HOUSE LTD | 639,465 | $3,002,000 | 0.20% |
Hillhouse Capital Management | 399,308 | $1,893,000 | 0.06% |
ArrowMark Colorado Holdings LLC | 703,375 | $3,334,000 | 0.03% |
PFM Health Sciences, LP | 121,848 | $578,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,200 | $755,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 77,024 | $365,000 | 0.01% |